NOS2 and obesity disorder: In the future, there might be a role for pharmacological adjuncts with inhibitory effects on iNOS in the treatment of IP conditions for patients with obesity or high-fat dietary habit under refractory scenarios or suboptimal pain control using routine analgesic regimens.